Effects of pre-operative continuing oral anticoagulants or antiplatelets on health outcomes among older patients with hip fracture: a systematic review and meta-analysis
- PMID: 40775083
- DOI: 10.1007/s00198-025-07572-4
Effects of pre-operative continuing oral anticoagulants or antiplatelets on health outcomes among older patients with hip fracture: a systematic review and meta-analysis
Abstract
Continuing antiplatelets during hip fracture surgery may be safe for older adults, while early surgery after discontinuation reduces hospital stay without adverse outcomes.
Purpose: The safety of continuing antiplatelets or direct oral anticoagulants (DOACs) before surgery in older patients with hip fractures remains uncertain. The feasibility of timely surgery after discontinuation also warrants further investigation.
Methods: We included studies of hip fracture patients aged ≥ 65 years taking antiplatelets or DOACs, comparing continuation versus discontinuation, or early versus delayed surgery. MEDLINE, EMBASE, Cochrane Library, and Web of Science were searched to November 2024. Risk of bias was assessed using the Newcastle-Ottawa Scale. Meta-analyses were conducted using a random-effects model to pool effect estimates. This study was registered with PROSPERO (CRD42022378334).
Results: Thirteen observational studies from nine countries involving 885 patients were included. There were no significant differences in transfusion rates in patients who continued the medication (Odds Ratio [OR] = 0.87; 95% Confidence Interval [CI]: 0.37 to 2.03). Surgery within 48 h of antiplatelet discontinuation was associated with shorter hospital stay (mean difference = - 5.71 days; 95% CI: - 8.36 to - 3.06) compared to those with delayed surgery, with no increase in transfusion (OR = 0.75; 95% CI: 0.04 to 13.73) and in-hospital mortality (OR = 0.49; 95% CI: 0.02 to 13.52). For DOAC users, no significant differences were observed in transfusion (OR = 1.09; 95% CI: 0.56 to 2.09) and 30-day mortality (OR = 1.53; 95% CI: 0.45 to 5.19) for early versus delayed surgery.
Conclusions: Surgery without discontinuing antiplatelets may be safe. Early surgery after discontinuing antiplatelets could reduce hospital stays without adverse outcomes. Randomized trials are needed to confirm these findings.
Keywords: Antiplatelet therapy; Direct oral anticoagulants; Hip fracture; Older adults.
© 2025. The Author(s), under exclusive licence to the International Osteoporosis Foundation and the Bone Health and Osteoporosis Foundation.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study did not involve primary data collection or direct interaction with patients. All data used were extracted from previously published studies that were publicly available. Ethical approval and patient consent were not required for this systematic review and meta-analysis. Consent for publication: Not required. Conflicts of interest: None.
Similar articles
-
Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis.Cochrane Database Syst Rev. 2025 Feb 24;2(2):CD013745. doi: 10.1002/14651858.CD013745.pub2. Cochrane Database Syst Rev. 2025. PMID: 39991882
-
Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.Cochrane Database Syst Rev. 2018 Jul 18;7(7):CD012584. doi: 10.1002/14651858.CD012584.pub2. Cochrane Database Syst Rev. 2018. PMID: 30019463 Free PMC article.
-
Cephalomedullary nails versus extramedullary implants for extracapsular hip fractures in older adults.Cochrane Database Syst Rev. 2022 Jan 26;1(1):CD000093. doi: 10.1002/14651858.CD000093.pub6. Cochrane Database Syst Rev. 2022. PMID: 35080771 Free PMC article.
-
Cell salvage for the management of postpartum haemorrhage.Cochrane Database Syst Rev. 2024 Dec 20;12(12):CD016120. doi: 10.1002/14651858.CD016120. Cochrane Database Syst Rev. 2024. PMID: 39704317
-
Surgical interventions for treating extracapsular hip fractures in older adults: a network meta-analysis.Cochrane Database Syst Rev. 2022 Feb 10;2(2):CD013405. doi: 10.1002/14651858.CD013405.pub2. Cochrane Database Syst Rev. 2022. PMID: 35142366 Free PMC article.
References
-
- Gong XF, Li XP, Zhang LX et al (2021) Current status and distribution of hip fractures among older adults in China. Osteoporos Int 32(9):1785–1793 - PubMed
-
- Lim SK, Choi K, Heo NH, Kim Y, Lim JY (2024) Characteristics of fragility hip fracture-related falls in the older adults: a systematic review. J Nutr Health Aging 28(10):100357 - PubMed
-
- Leal J, Gray AM, Prieto-Alhambra D et al (2016) Impact of hip fracture on hospital care costs: a population-based study. Osteoporos Int 27(2):549–558 - PubMed
-
- Li S, Sun T, Liu Z (2016) Excess mortality of 1 year in elderly hip fracture patients compared with the general population in Beijing, China. Arch Osteoporos 11(1):35 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical